These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Current evidence on the relationship between four polymorphisms in the matrix metalloproteinases (MMP) gene and breast cancer risk: a meta-analysis. Zhou P, Du LF, Lv GQ, Yu XM, Gu YL, Li JP, Zhang C. Breast Cancer Res Treat; 2011 Jun; 127(3):813-8. PubMed ID: 21161369 [Abstract] [Full Text] [Related]
28. [Association of functional polymorphisms in matrix metalloproteinase-2 (MMP-2) and MMP-9 genes with risk of gastric cancer in a Chinese population]. Zhang XM, Miao XP, Xiong P, Yu CY, Tan W, Qu SN, Sun T, Zhou YF, Lin DX. Ai Zheng; 2004 Nov; 23(11):1233-7. PubMed ID: 15522165 [Abstract] [Full Text] [Related]
29. A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease. Vasků A, Goldbergová M, Izakovicová Hollá L, Sisková L, Groch L, Beránek M, Tschöplová S, Znojil V, Vácha J. Matrix Biol; 2004 Jan; 22(7):585-91. PubMed ID: 14996438 [Abstract] [Full Text] [Related]
30. Genetic polymorphisms of the matrix metalloproteinase-3 (MMP-3) and tissue inhibitors of matrix metalloproteinases-1 (TIMP-1) modulate the development of ankylosing spondylitis. Wei JC, Lee HS, Chen WC, Shiu LJ, Yang SF, Wong RH. Ann Rheum Dis; 2009 Nov; 68(11):1781-6. PubMed ID: 19019896 [Abstract] [Full Text] [Related]
33. Matrix metalloproteinase-1, -3, and -9 gene polymorphisms and the risk of idiopathic dilated cardiomyopathy in a Chinese Han population. Tang LJ, Chen XF, Zhu M, Jiang JJ, Lu XB, Du YX, Wang B, Fang CF, Xue YS, Shen WF. Clin Biochem; 2007 Dec; 40(18):1427-30. PubMed ID: 18028894 [Abstract] [Full Text] [Related]
34. No association between the polymorphisms in matrix metalloproteinase-1 and matrix metalloproteinase-3 promoter regions and colorectal cancer in Chinese. Xu E, Lai M, Lŭ B, Xing X, Huang Q. Dis Colon Rectum; 2006 Sep; 49(9):1439-44. PubMed ID: 16937230 [Abstract] [Full Text] [Related]
36. The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma. Zhang J, Jin X, Fang S, Wang R, Li Y, Wang N, Guo W, Wang Y, Wen D, Wei L, Dong Z, Kuang G. Carcinogenesis; 2005 Oct; 26(10):1748-53. PubMed ID: 15930031 [Abstract] [Full Text] [Related]
37. Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: a case-control study in a Spanish population. Román-García P, Coto E, Reguero JR, Cannata-Andía JB, Lozano I, Avanzas P, Morís C, Rodríguez I. Coron Artery Dis; 2009 Sep; 20(6):383-6. PubMed ID: 19620856 [Abstract] [Full Text] [Related]